81
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
Condition(s): Multiple Sclerosis Last Updated: November 5, 2012Completed
236 Clinical Trials for: Beta-interferons, Page 5 of 12
Hide Studies Not Seeking New Volunteers
82
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
Condition(s): Multiple Sclerosis Last Updated: February 22, 2013Recruiting
83
Gene Expression in MS Patients Before and During Treatment With Interferon-beta
Condition(s): Multiple Sclerosis Last Updated: July 26, 2010Completed
84
Longitudinal Study in Clinically Isolated Syndrome (CIS) Patients Treated With Interferon Beta
Condition(s): Clinically Isolated Syndrome Last Updated: December 6, 2011Terminated
85
Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients
Condition(s): Multiple Sclerosis Last Updated: January 24, 2012Completed
86
Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases
Condition(s): Colorectal Carcinoma; Metastases Last Updated: July 10, 2009Completed
87
Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
Condition(s): Multiple Sclerosis Last Updated: March 2, 2006Active, not recruiting
88
Combination Therapy Using Cellcept and Rebif in RRMS
Condition(s): Multiple Sclerosis Last Updated: November 14, 2012Completed
89
Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.
Condition(s): Relapsing Remitting Multiple Sclerosis Last Updated: March 8, 2013Not yet recruiting
90
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Condition(s): Relapsing Remitting Multiple Sclerosis Last Updated: September 13, 2012Terminated
91
Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Condition(s): Multiple Sclerosis Last Updated: January 26, 2010Completed
92
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)
Condition(s): Multiple Sclerosis Last Updated: January 24, 2013Completed
93
Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
Condition(s): Multiple Sclerosis Last Updated: June 16, 2009Completed
94
Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.
Condition(s): Demyelinating Disorders; Multiple Sclerosis; Optic Neuritis; Myelitis; Neuritis Last Updated: November 20, 2009Withdrawn
95
Long-Term Safety and Efficacy Study of BIIB017 (ATTAIN)
Condition(s): Relapsing Multiple Sclerosis Last Updated: November 1, 2012Enrolling by invitation
96
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis
Condition(s): Relapsing-Remitting Multiple Sclerosis Last Updated: December 21, 2005Terminated
97
Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)
Condition(s): Multiple Sclerosis Last Updated: June 7, 2012Completed
98
Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers
Condition(s): Multiple Sclerosis Last Updated: June 3, 2009Completed
99
MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)
Condition(s): Multiple Sclerosis Last Updated: May 14, 2013Recruiting
100
Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.
Condition(s): Multiple Sclerosis Last Updated: August 20, 2012Active, not recruiting
